Detalles de la búsqueda
1.
A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study.
BMC Gastroenterol
; 22(1): 151, 2022 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35346070
2.
Angiographic classification of patterns of restenosis following femoropopliteal artery intervention: A proposed scoring system.
Catheter Cardiovasc Interv
; 90(4): 639-646, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28795488
3.
A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: final results of the AGILITY trial.
Catheter Cardiovasc Interv
; 82(3): 352-9, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22927100
4.
Extended-release niacin or ezetimibe and carotid intima-media thickness.
N Engl J Med
; 361(22): 2113-22, 2009 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-19915217
5.
Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté versus TAXUS express stents.
J Interv Cardiol
; 25(4): 353-63, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22612261
6.
Pressure-Controlled Intermittent Coronary Sinus Occlusion: A Novel Approach to Improve Microvascular Flow and Reduce Infarct Size in STEMI.
Cardiovasc Revasc Med
; 45: 9-14, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35918254
7.
Long-term benefit of the TAXUS Liberté stent in small vessels and long lesions. TAXUS ATLAS program.
Circ J
; 75(5): 1120-9, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21467655
8.
Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation.
Catheter Cardiovasc Interv
; 73(7): 847-58, 2009 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19425053
9.
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction.
J Interv Cardiol
; 22(4): 378-84, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19496901
10.
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
Eur Heart J
; 29(13): 1625-34, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18556716
11.
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial.
Catheter Cardiovasc Interv
; 72(7): 917-24, 2008 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19016469
12.
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
N Engl J Med
; 350(3): 221-31, 2004 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14724301
13.
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
N Engl J Med
; 346(13): 957-66, 2002 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-11919304
14.
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).
Am J Cardiol
; 99(12): 1680-6, 2007 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17560875
15.
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
Am J Cardiol
; 100(2): 206-10, 2007 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17631071
16.
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitors.
Am J Cardiol
; 99(2): 202-7, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17223419
17.
Novel Catheter Device Using Renal Artery Protection to Reduce Contrast-Associated Acute Kidney Injury.
Cardiovasc Revasc Med
; 45: 15-17, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35810112
18.
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Circulation
; 111(13): 1611-8, 2005 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15811868
19.
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.
J Am Coll Cardiol
; 45(8): 1193-200, 2005 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-15837248
20.
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.
J Am Coll Cardiol
; 45(9): 1397-405, 2005 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-15862409